AACR: Human Papillomavirus Tied to Lung Cancer
Several high-risk forms of human papillomavirus (HPV) antibodies may be associated with an increased risk of lung cancer, according to research presented at the annual meeting of the American Association for Cancer Research, held April 2 to 6 in Orlando, Fla.
MONDAY, April 4 (HealthDay News) -- Several high-risk forms of human papillomavirus (HPV) antibodies may be associated with an increased risk of lung cancer, according to research presented at the annual meeting of the American Association for Cancer Research, held April 2 to 6 in Orlando, Fla.
Devasena Anantharaman, Ph.D., of the International Agency for Research on Cancer in Lyon, France, and colleagues determined the presence of several high-risk and low-risk types of HPV using serological tests in 1,633 individuals with lung cancer and 2,729 matched controls from six central European countries.
The investigators found that antibodies to proteins in eight types of high-risk HPV were significantly increased among individuals with lung cancer. However, a low prevalence of antibodies to all types of HPV tested was found among controls. The investigators also found that smoking did not account for this effect, as the results were consistent in current smokers, former smokers, and those who never smoked.
"While a number of previous studies have demonstrated the presence of HPV in lung cancer, their statistical power has been limited by small average sample size and variations in methodology," Anantharaman said in a statement. "We know that HPV can reach the lung, but whether HPV can cause frank malignancies is a question we hope to answer."
Abstract No. 1890More Information
Related Content
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More
